WIM
MIRM icon

Westside Investment Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Westside Investment Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.1K Hold
300
– – ﹤0.01% 722
2026
Q1 		$27.7K Hold
300
– – ﹤0.01% 769
2025
Q4 		$23.7K Hold
300
– – ﹤0.01% 812
2025
Q3 		$22K Buy
+300
New +$19.1K ﹤0.01% 846

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Westside Investment Management's MIRM Position: Q2 2026 in Review

Westside Investment Management held its Mirum Pharmaceuticals (MIRM) position steady in Q2 2026 at 300 shares worth $35.1K. The position accounts for ﹤0.01% of the portfolio, ranked #722.

Westside Investment Management first reported a position in MIRM in Q3 2025 and has held it in 4 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Westside Investment Management held 300 shares of Mirum Pharmaceuticals worth $35.1K as of Q2 2026.
  • Westside Investment Management left its Mirum Pharmaceuticals share count unchanged in Q2 2026.
  • Mirum Pharmaceuticals made up ﹤0.01% of Westside Investment Management's portfolio in Q2 2026, its #722 holding.
  • Westside Investment Management first reported a position in Mirum Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Westside Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.